In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy Is Associated with Significantly Worse Clinical Outcomes Than Only an Incomplete Thyroglobulin Response

Citations Over TimeTop 10% of 2011 papers

Abstract

A structural incomplete response to initial therapy is associated with significantly worse clinical outcome than a biochemical incomplete response to therapy.

Related Papers

• → The Role of Routine Diagnostic Radioiodine Whole-Body Scintigraphy in Patients with High-Risk Differentiated Thyroid Cancer(2010)31 cited
• → Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients’ Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial(2021)10 cited
• → Serum Thyroglobulin in the Management of Patients With Thyroid Cancer(1982)52 cited
• Effect of Antithyroglobulin Antibody on Thyroglobulin About Differentiated Thyroid Cancer Patients(2006)
• → Modern Management of Differentiated Thyroid Cancer(2003)9 cited